Conformational Asn 187Asp/Lys antithrombin variants and thrombosis. Clinical and biological features in 13 new heterozygotes

Thrombosis and Haemostasis

Volumn 93, Issue 1, 2005, Pages 57-62

  Picard, Véronique ^a,b   Bauters, Anne ^c   Khairy, Mahnouch ^b   Ochat, Nadège ^a   Jude, Brigitte ^c   Aiach, Martine ^a   Alhenc Gelas, Martine ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Antithrombin; Conformational variant; Serpin; Thrombophilia

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN; ASPARAGINE; LYSINE; ANTITHROMBIN III;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; GENE MUTATION; HETEROZYGOSITY; HETEROZYGOTE; HUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN VARIANT; RISK FACTOR; STRUCTURE ACTIVITY RELATION; THERMOSTABILITY; THROMBOSIS; VEIN THROMBOSIS; ADOLESCENT; CASE REPORT; FAMILY HEALTH; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PEDIGREE; PREGNANCY; PREGNANCY COMPLICATION;

ADOLESCENT; ADULT; ANTITHROMBIN III; DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MUTATION, MISSENSE; PEDIGREE; POLYMORPHISM, GENETIC; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PROTEIN CONFORMATION; THROMBOSIS;

EID: 12344264070     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH04-08-0477     Document Type: Article

References (27)

1. Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh 1965; 13: 516-30.
2. Heijboer H, Brandjes DP, Buller HR, et al. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. N Engl J Med 1990; 323: 1512-6.
3. Rosendaal FR. Risks factors for venous thrombotic disease. Thromb Haemost 1996; 82: 616-9.
4. Tait RC, Walker ID, Perry DJ, et al. Prevalence of antithrombin deficiency in the healthy population. Br J Haematol 1994; 87: 106-12.
5. Lane DA, Bayston T, Olds RJ, et al. Antithrombin mutation database: 2nd (1997) update. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1997; 77: 197-211.
6. Perry DJ, Marshall C, Borg JY, et al. Two novel antithrombin variants, Asn187Asp and Asn187Lys, indicate a functional role for asparagine 187. Blood Coagul Fibrinolysis 1995; 6: 51-4.
7. Bruce D, Perry DJ, Borg JY, et al. Thromboembolic disease due to thermolabile conformational changes of antithrombin Rouen-VI (187 Asn←Asp). J Clin Invest 1994; 94: 2265-74.
8. Beauchamp NJ, Pike RN, Daly M, et al. Antithrombins Wibble and Wobble (T85M/K): archetypal conformational diseases with in vivo latent-transition, thrombosis, and heparin activation. Blood 1998; 92: 2696-706.
9. Picard V, Dautzenberg MD, Villoutreix BO, et al. Antithrombin Phe229Leu: a new homozygous variant leading to spontaneous antithrombin polymerization in vivo associated with severe childhood thrombosis. Blood 2003; 102: 919-25.
10. Creagh MD, Roberts IF, Clark DJ, et al. Familial antithrombin III deficiency and Mycoplasma pneumoniae pneumonia. J Clin Pathol 1991; 44: 870-1.
11. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
12. Picard V, Bura A, Emmerich J, et al. Molecular bases of antithrombin deficiency in French families: identification of seven novel mutations in the antithrombin gene. Br J Haematol 2000; 110: 731-4.
13. Sas G, Pepper DS, Cash JD. Plasma and serum antithrombin III: differentiation by crossed immunoelectrophoresis. Thromb Res 1975; 6: 87-91.
14. Picard V, Marque PE, Paolucci F, et al. Topology of the stable serpin-protease complexes revealed by an autoantibody that fails to react with the monomeric conformers of antithrombin. J Biol Chem 1999; 274: 4586-93.
15. McKay EJ. A simple two-step procedure for the isolation of antithrombin III from biological fluids. Thromb Res 1981; 21: 375-82.
16. Wardell MR, Chang WS, Bruce D, et al. Preparative induction and characterization of L-antithrombin: a structural homologue of latent plasminogen activator inhibitor-1. Biochemistry 1997; 36: 13133-42.
17. Carrell RW, Huntington JA, Mushunje A, et al. The conformational basis of thrombosis. Thromb Haemost 2001; 86: 14-22.
18. Eldor A. Thrombophilia, thrombosis and pregnancy. Thromb Haemost 2001; 86: 104-11.
19. Martinelli I, Legnani C, Bucciarelli P, et al. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia. Thromb Haemost 2001; 86: 800-3.
20. Conard J, Horellou MH, Van Dreden P, et al. Thrombosis and pregnancy in congenital deficiencies in AT III, protein C or protein S: study of 78 women. Thromb Haemost 1990; 63: 319-20.
21. Pabinger I, Schneider B. Thrombotic risk in hereditary antithrombin III, protein C, or protein S deficiency. Arterioscler Thromb Vasc Biol 1996; 16: 742-8.
22. Walker ID. Thrombophilia in pregnancy. J Clin Pathol 2000; 53: 573-80.
23. Hellgren M. Hemostasis during normal pregnancy and the puerperium. Semin Thromb Hemost 2003; 2: 125-30.
24. Eichinger S, Weltermann A, Philipp K, et al. Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden. Thromb Haemost 1999; 82: 1232-6.
25. Irving JA, Pike RN, Lesk AM, et al. Phylogeny of the serpin superfamily: implications of patterns of amino acid conservation for structure and function. Genome Res 2000; 10: 1845-64.
26. Gettins PG. The F-helix of serpins plays an essential, active role in the proteinase inhibition mechanism. FEBS Lett 2002; 523: 2-6.
27. Schreuder HA, de Boer B, Dijkema R, et al. The intact and cleaved human antithrombin III complex as a model for serpin-proteinase interactions. Nat Struct Biol 1994; 1: 48-54.